Drug
Tobramycin And Dexamethasone
Important: Reactions below are the flagged terms from this drug’s
FAERS report history (min. 3 co-reports per term) — PRR/ROR indicate
disproportionality in spontaneous reporting, not causation.
Data from FDA FAERS via openFDA. Last recalculated: 2026-09-14.
| Reaction | Co-reports (a) | PRR | ROR | Signal | |
|---|---|---|---|---|---|
| 1 | Intraocular Pressure Increased | 100 | 50.1 | 51.7 | signal |
| 2 | Retinal Detachment | 48 | 33.5 | 34.0 | signal |
| 3 | Eye Infection | 49 | 28.0 | 28.4 | signal |
| 4 | Eye Pain | 241 | 28.0 | 30.1 | signal |
| 5 | Photophobia | 81 | 27.8 | 28.5 | signal |
| 6 | Eye Inflammation | 38 | 25.8 | 26.1 | signal |
| 7 | Conjunctivitis | 73 | 25.5 | 26.0 | signal |
| 8 | Uveitis | 53 | 25.1 | 25.5 | signal |
| 9 | Ocular Hyperaemia | 167 | 22.9 | 24.1 | signal |
| 10 | Eye Discharge | 34 | 21.3 | 21.5 | signal |
| 11 | Ocular Discomfort | 36 | 21.2 | 21.5 | signal |
| 12 | Eye Irritation | 168 | 19.3 | 20.3 | signal |
| 13 | Lacrimation Increased | 85 | 18.2 | 18.7 | signal |
| 14 | Glaucoma | 51 | 16.9 | 17.2 | signal |
| 15 | Eye Swelling | 89 | 15.4 | 15.8 | signal |
| 16 | Visual Acuity Reduced | 76 | 14.5 | 14.8 | signal |
| 17 | Osteopenia | 34 | 14.3 | 14.4 | signal |
| 18 | Economic Problem | 32 | 13.3 | 13.4 | signal |
| 19 | Eyelid Oedema | 24 | 13.1 | 13.2 | signal |
| 20 | Eyelid Ptosis | 20 | 12.6 | 12.6 | signal |
| 21 | Eye Pruritus | 64 | 12.4 | 12.6 | signal |
| 22 | Eye Disorder | 57 | 11.1 | 11.3 | signal |
| 23 | Ear Discomfort | 17 | 10.6 | 10.7 | signal |
| 24 | Blindness Unilateral | 23 | 10.4 | 10.5 | signal |
| 25 | Vitreous Floaters | 15 | 9.8 | 9.9 | signal |
| 26 | Cataract | 91 | 9.8 | 10.1 | signal |
| 27 | Hyperlipidaemia | 18 | 9.6 | 9.6 | signal |
| 28 | Dry Eye | 72 | 9.5 | 9.7 | signal |
| 29 | Toxic Skin Eruption | 15 | 9.5 | 9.5 | signal |
| 30 | Intervertebral Disc Degeneration | 13 | 8.9 | 9.0 | signal |
| 31 | Madarosis | 16 | 8.7 | 8.8 | signal |
| 32 | Vision Blurred | 180 | 8.4 | 8.9 | signal |
| 33 | Impaired Quality Of Life | 18 | 8.0 | 8.0 | signal |
| 34 | Mitral Valve Incompetence | 14 | 7.9 | 7.9 | signal |
| 35 | Ejection Fraction Decreased | 19 | 7.8 | 7.8 | signal |
| 36 | Seasonal Allergy | 17 | 7.7 | 7.7 | signal |
| 37 | Eye Haemorrhage | 16 | 7.6 | 7.7 | signal |
| 38 | Tooth Abscess | 12 | 7.5 | 7.5 | signal |
| 39 | Arteriosclerosis | 11 | 7.5 | 7.5 | signal |
| 40 | Product Use Complaint | 18 | 7.4 | 7.5 | signal |
| 41 | Tinnitus | 53 | 7.4 | 7.5 | signal |
| 42 | End Stage Renal Disease | 21 | 7.3 | 7.3 | signal |
| 43 | Cyst | 14 | 7.2 | 7.2 | signal |
| 44 | Chronic Kidney Disease | 80 | 6.7 | 6.8 | signal |
| 45 | Tendonitis | 16 | 6.6 | 6.6 | signal |
| 46 | Visual Impairment | 119 | 6.2 | 6.4 | signal |
| 47 | Supraventricular Tachycardia | 9 | 6.0 | 6.0 | signal |
| 48 | Post Procedural Complication | 18 | 6.0 | 6.0 | signal |
| 49 | Blindness | 38 | 6.0 | 6.0 | signal |
| 50 | Haemorrhoids | 18 | 5.9 | 5.9 | signal |
| 51 | Temperature Intolerance | 9 | 5.6 | 5.6 | signal |
| 52 | Presyncope | 21 | 5.5 | 5.6 | signal |
| 53 | Ventricular Extrasystoles | 9 | 5.5 | 5.5 | signal |
| 54 | Disability | 17 | 5.5 | 5.5 | signal |
| 55 | Diplopia | 22 | 5.4 | 5.4 | signal |
| 56 | Inflammation | 43 | 5.4 | 5.4 | signal |
| 57 | Anhedonia | 22 | 5.3 | 5.3 | signal |
| 58 | Bursitis | 10 | 5.3 | 5.3 | signal |
| 59 | Staphylococcal Infection | 27 | 5.2 | 5.2 | signal |
| 60 | Secretion Discharge | 10 | 5.2 | 5.2 | signal |
| 61 | Sleep Apnoea Syndrome | 15 | 5.0 | 5.0 | signal |
| 62 | Rash Maculo-papular | 17 | 4.9 | 4.9 | signal |
| 63 | Immune System Disorder | 10 | 4.9 | 4.9 | signal |
| 64 | Macular Degeneration | 9 | 4.8 | 4.8 | signal |
| 65 | Bacterial Infection | 14 | 4.8 | 4.8 | signal |
| 66 | Product Packaging Quantity Issue | 8 | 4.7 | 4.7 | signal |
| 67 | Photosensitivity Reaction | 12 | 4.7 | 4.7 | signal |
| 68 | Hypomagnesaemia | 10 | 4.6 | 4.6 | signal |
| 69 | Vitamin D Deficiency | 7 | 4.6 | 4.6 | signal |
| 70 | Ear Infection | 19 | 4.6 | 4.6 | signal |
| 71 | Pelvic Pain | 13 | 4.6 | 4.6 | signal |
| 72 | Ligament Sprain | 7 | 4.5 | 4.5 | signal |
| 73 | Dermatitis Contact | 8 | 4.5 | 4.5 | signal |
| 74 | Impaired Driving Ability | 8 | 4.5 | 4.5 | signal |
| 75 | Emphysema | 7 | 4.4 | 4.4 | signal |
| 76 | Osteomyelitis | 12 | 4.2 | 4.2 | signal |
| 77 | Toxic Epidermal Necrolysis | 10 | 4.2 | 4.2 | signal |
| 78 | Coronary Artery Disease | 20 | 4.2 | 4.2 | signal |
| 79 | Product Administration Error | 13 | 4.2 | 4.2 | signal |
| 80 | Face Oedema | 11 | 4.1 | 4.2 | signal |
| 81 | Carpal Tunnel Syndrome | 9 | 4.1 | 4.1 | signal |
| 82 | Muscle Atrophy | 8 | 4.1 | 4.1 | signal |
| 83 | Mydriasis | 8 | 4.0 | 4.0 | signal |
| 84 | Rotator Cuff Syndrome | 8 | 4.0 | 4.0 | signal |
| 85 | Ear Pain | 12 | 3.9 | 4.0 | signal |
| 86 | Hiatus Hernia | 8 | 3.9 | 3.9 | signal |
| 87 | Gastrooesophageal Reflux Disease | 49 | 3.9 | 3.9 | signal |
| 88 | Injury | 43 | 3.9 | 3.9 | signal |
| 89 | Cardiomyopathy | 9 | 3.9 | 3.9 | signal |
| 90 | Toothache | 11 | 3.9 | 3.9 | signal |
| 91 | Sinus Disorder | 12 | 3.9 | 3.9 | signal |
| 92 | Hypoaesthesia Oral | 9 | 3.8 | 3.8 | signal |
| 93 | Intervertebral Disc Protrusion | 13 | 3.8 | 3.8 | signal |
| 94 | Sinus Congestion | 8 | 3.8 | 3.8 | signal |
| 95 | Pleural Effusion | 35 | 3.7 | 3.7 | signal |
| 96 | Deafness | 15 | 3.7 | 3.7 | signal |
| 97 | Oral Herpes | 11 | 3.6 | 3.6 | signal |
| 98 | Breast Pain | 6 | 3.6 | 3.6 | signal |
| 99 | Body Height Decreased | 6 | 3.5 | 3.5 | signal |
| 100 | Infusion Site Pain | 7 | 3.5 | 3.5 | signal |
| 101 | Dental Caries | 6 | 3.5 | 3.5 | signal |
| 102 | Increased Tendency To Bruise | 5 | 3.5 | 3.5 | signal |
| 103 | Insurance Issue | 8 | 3.4 | 3.4 | signal |
| 104 | Erythema Multiforme | 5 | 3.4 | 3.4 | signal |
| 105 | Incorrect Route Of Product Administration | 9 | 3.4 | 3.4 | signal |
| 106 | Deformity | 5 | 3.4 | 3.4 | signal |
| 107 | Scab | 6 | 3.4 | 3.4 | signal |
| 108 | Sputum Discoloured | 5 | 3.4 | 3.4 | signal |
| 109 | Drug Dispensing Error | 8 | 3.3 | 3.3 | signal |
| 110 | Eosinophilia | 9 | 3.3 | 3.3 | signal |
| 111 | Post Procedural Haemorrhage | 6 | 3.3 | 3.3 | signal |
| 112 | Discomfort | 31 | 3.3 | 3.3 | signal |
| 113 | Anaphylactic Shock | 13 | 3.2 | 3.2 | signal |
| 114 | Hypersensitivity | 94 | 3.2 | 3.3 | signal |
| 115 | Body Temperature Decreased | 5 | 3.2 | 3.2 | signal |
| 116 | Skin Reaction | 7 | 3.2 | 3.2 | signal |
| 117 | Sleep Disorder Due To A General Medical Condition | 8 | 3.2 | 3.2 | signal |
| 118 | Restless Legs Syndrome | 9 | 3.2 | 3.2 | signal |
| 119 | Dialysis | 7 | 3.1 | 3.1 | signal |
| 120 | Swelling Face | 32 | 3.1 | 3.2 | signal |
| 121 | Dermatitis | 10 | 3.1 | 3.1 | signal |
| 122 | Dermatitis Atopic | 24 | 3.1 | 3.1 | signal |
| 123 | Renal Injury | 14 | 3.0 | 3.0 | signal |
| 124 | Musculoskeletal Discomfort | 8 | 3.0 | 3.0 | signal |
| 125 | Rectal Haemorrhage | 20 | 3.0 | 3.0 | signal |
| 126 | Stevens-johnson Syndrome | 10 | 2.9 | 2.9 | signal |
| 127 | Basal Cell Carcinoma | 7 | 2.9 | 2.9 | signal |
| 128 | Osteonecrosis Of Jaw | 11 | 2.8 | 2.8 | signal |
| 129 | Coronary Artery Occlusion | 6 | 2.8 | 2.8 | signal |
| 130 | Blood Thyroid Stimulating Hormone Increased | 4 | 2.8 | 2.8 | no signal |
| 131 | Muscle Tightness | 7 | 2.8 | 2.8 | signal |
| 132 | Drug Reaction With Eosinophilia And Systemic Symptoms | 11 | 2.7 | 2.8 | signal |
| 133 | Emotional Distress | 52 | 2.7 | 2.8 | signal |
| 134 | Pemphigus | 5 | 2.6 | 2.6 | no signal |
| 135 | Multi-organ Failure | 7 | 2.5 | 2.6 | signal |
| 136 | Activities Of Daily Living Impaired | 8 | 2.5 | 2.5 | signal |
| 137 | Ovarian Cyst | 4 | 2.5 | 2.5 | no signal |
| 138 | Bone Loss | 6 | 2.5 | 2.5 | signal |
| 139 | Blood Triglycerides Increased | 7 | 2.5 | 2.5 | signal |
| 140 | Gallbladder Disorder | 7 | 2.5 | 2.5 | signal |
| 141 | Product Prescribing Error | 9 | 2.4 | 2.4 | signal |
| 142 | Dysgeusia | 28 | 2.4 | 2.4 | signal |
| 143 | Rebound Effect | 4 | 2.3 | 2.3 | no signal |
| 144 | Hepatocellular Injury | 5 | 2.2 | 2.2 | no signal |
| 145 | Hypoacusis | 15 | 2.2 | 2.2 | signal |
| 146 | Metastases To Lung | 4 | 2.2 | 2.2 | no signal |
| 147 | Nightmare | 12 | 2.2 | 2.2 | signal |
| 148 | Eczema | 17 | 2.2 | 2.2 | signal |
| 149 | Extrapyramidal Disorder | 8 | 2.0 | 2.0 | no signal |
| 150 | Tardive Dyskinesia | 9 | 2.0 | 2.0 | no signal |
| 151 | Bone Density Decreased | 10 | 2.0 | 2.0 | signal |
| 152 | Product Quality Issue | 42 | 2.0 | 2.0 | no signal |
| 153 | Affect Lability | 3 | 2.0 | 2.0 | no signal |
| 154 | Decreased Immune Responsiveness | 3 | 2.0 | 2.0 | no signal |
| 155 | Metastases To Bone | 5 | 2.0 | 2.0 | no signal |
| 156 | Inability To Afford Medication | 3 | 1.9 | 1.9 | no signal |
| 157 | Incorrect Route Of Drug Administration | 11 | 1.9 | 1.9 | no signal |
| 158 | Product Dose Omission In Error | 8 | 1.9 | 1.9 | no signal |
| 159 | Incorrect Product Administration Duration | 6 | 1.9 | 1.9 | no signal |
| 160 | Product Odour Abnormal | 3 | 1.8 | 1.8 | no signal |
| 161 | Skeletal Injury | 3 | 1.8 | 1.8 | no signal |
| 162 | Diabetes Mellitus Inadequate Control | 5 | 1.8 | 1.8 | no signal |
| 163 | Glycosylated Haemoglobin Increased | 7 | 1.8 | 1.8 | no signal |
| 164 | Plasma Cell Myeloma | 10 | 1.6 | 1.6 | no signal |
| 165 | Diabetic Ketoacidosis | 6 | 1.6 | 1.6 | no signal |
| 166 | Osteonecrosis | 8 | 1.5 | 1.5 | no signal |
| 167 | Multiple Fractures | 4 | 1.5 | 1.5 | no signal |
| 168 | Expired Product Administered | 8 | 1.5 | 1.5 | no signal |
| 169 | Product Dispensing Error | 5 | 1.5 | 1.5 | no signal |
| 170 | Psoriatic Arthropathy | 9 | 1.4 | 1.4 | no signal |
| 171 | Product Taste Abnormal | 3 | 1.4 | 1.4 | no signal |
| 172 | Hair Texture Abnormal | 3 | 1.4 | 1.4 | no signal |
| 173 | Device Failure | 3 | 1.3 | 1.3 | no signal |
| 174 | Product Storage Error | 16 | 1.2 | 1.2 | no signal |
| 175 | Application Site Pain | 4 | 1.2 | 1.2 | no signal |
| 176 | Skin Irritation | 8 | 1.1 | 1.1 | no signal |
| 177 | Synovitis | 3 | 1.1 | 1.1 | no signal |
| 178 | Product Administered At Inappropriate Site | 3 | 1.1 | 1.1 | no signal |
| 179 | Device Dislocation | 6 | 0.9 | 0.9 | no signal |
| 180 | Accidental Exposure To Product | 13 | 0.8 | 0.8 | no signal |
| 181 | Injection Site Swelling | 9 | 0.8 | 0.8 | no signal |
| 182 | Pharmaceutical Product Complaint | 3 | 0.7 | 0.7 | no signal |